(Q48262198)

10 February 2018

title

MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin (English)

1 reference

10 February 2018

0 references

Alain Roulet

1

1 reference

10 February 2018

Olivier Puel

2

1 reference

10 February 2018

Stéphane Gesta

3

1 reference

10 February 2018

Jean-François Lepage

4

1 reference

10 February 2018

Marlene Drag

5

1 reference

10 February 2018

Mark Soll

6

1 reference

10 February 2018

Michel Alvinerie

7

1 reference

10 February 2018

Thierry Pineau

8

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

10 February 2018

European Journal of Pharmacology

published in

1 reference

10 February 2018

volume

460

1 reference

10 February 2018

issue

2-3

1 reference

10 February 2018

page(s)

85-91

1 reference

10 February 2018

Ivermectin, an antiparasitic agent

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Ivermectin: a review of efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Anthelmintics. A comparative review of their clinical pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Mechanism of action of P-glycoprotein in relation to passive membrane permeation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

The biology of the P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Modes of action of anthelmintic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Ivermectin excretion by isolated functionally intact brain endothelial capillaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Safety of moxidectin in avermectin-sensitive collies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Reversal of P-glycoprotein-associated multidrug resistance by ivermectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902955-2

10.1016/S0014-2999(02)02955-2

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018